| |
p value
|
Odds ratio (95 %CI)
|
|---|
|
Univariate analysis
| | |
|
Age
|
0.14
| |
|
Gender
|
0.72
| |
|
BMI
|
0.73
| |
|
Dexmedetomidine
|
0.067
| |
|
Catecholamine (dopamine and/or dobutamine)
|
0.52
| |
|
Beta-blocker
|
0.15
| |
|
Fentanyl
|
0.2
| |
|
CRP
|
0.52
| |
|
Hypertension
|
0.42
| |
|
Valvular disease
|
0.74
| |
|
Heart failure
|
1
| |
|
Left ventricular hypertrophy
|
1
| |
|
Diabetes
|
0.72
| |
|
Smoking
|
0.48
| |
|
APACHE II score
|
0.7
| |
|
SOFA score
|
0.33
| |
|
Intubation days
|
1
| |
|
Multivariate analysis
| | |
|
Age
|
0.13
|
1.1 (0.97–1.24)
|
|
Dexmedetomidine
|
0.045
|
9.75 (1.05–90.8)
|
|
Beta-blocker
|
0.36
|
0.69 (0.32–1.51)
|
- Univariate analysis was conducted by Fisher’s exact test. Multivariate logistic regression analysis was conducted using age, Dex, and beta-blocker, extracted because their p values in univariate analysis were not exceeding 0.15
-
BMI body mass index, CRP serum level of C-reactive protein, APACHE II score Acute Physiology and Chronic Health Evaluation II score, SOFA score Sequential Organ Failure Assessment score
